In animal models, subcutaneous semaglutide alters genes linked to atherosclerosis and dose-independently reduces aortic plaque lesions in non-diabetic low-density lipoprotein receptor-deficient mice [33]
Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Dizziness Feeling bloated Belching Gas Heartburn Serious side effects include thyroid tumors Semaglutide may cause the following: Inflammation of the pancreas, Gallbladder symptoms, Low blood sugar, Kidney symptoms, Allergic reactions, Change in vision in patients with Type 2 diabetes, Increased heart rate, depression, or thoughts of suicide
33.2 4.5 kg/m
To help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation, it is expected that Judge Pratter will establish a bellwether process to prepare a small group of Ozempic or Wegovy lawsuits for early trial dates
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is a peptide-based drug requiring specific storage conditions to maintain potency and safety